Mental health in persons with von Willebrand disease in the United States - a large national database study

Andrew D Tran; Emily Waller; Joana M Mack; Shelley E Crary; Divyaswathi Citla-Sridhar

doi:10.1016/j.jtha.2024.02.015

Mental health in persons with von Willebrand disease in the United States - a large national database study

J Thromb Haemost. 2024 Mar 5:S1538-7836(24)00119-3. doi: 10.1016/j.jtha.2024.02.015. Online ahead of print.

Authors

Andrew D Tran¹, Emily Waller², Joana M Mack³, Shelley E Crary³, Divyaswathi Citla-Sridhar³

Affiliations

¹ Division of Hematology/Oncology, Department of Pediatrics, University of Arkansas for the Medical Sciences, Little Rock, Arkansas, USA; Arkansas Children's Hospital, Little Rock, Arkansas, USA. Electronic address: adtran@uams.edu.
² Division of Hematology/Oncology, Department of Pediatrics, University of Arkansas for the Medical Sciences, Little Rock, Arkansas, USA.
³ Division of Hematology/Oncology, Department of Pediatrics, University of Arkansas for the Medical Sciences, Little Rock, Arkansas, USA; Arkansas Children's Hospital, Little Rock, Arkansas, USA.

PMID: 38453024
DOI: 10.1016/j.jtha.2024.02.015

Abstract

Background: There are very few large population-based studies studying mental health in persons with von Willebrand disease (PwVWD).

Objectives: We aim to assess prevalence of depression and anxiety in PwVWD over a period of 20 years and identify bleeding symptoms that may be more likely associated with depression and anxiety in PwVWD.

Methods: This is a retrospective cohort study using a deidentified national dataset from 1118 hospitals with 176 million patients. Cases were defined as patients aged 0-110 years, both male and female, with von Willebrand disease (VWD), without hemophilia. Controls were defined as patients aged 0-110 years, both male and female, without VWD or hemophilia. We compared rates of depression and anxiety in cases and controls and by type of bleeding symptoms.

Results: We identified 66 367 PwVWD and 183 890 766 controls. The prevalence of depression (23.12% vs 8.62%; p ≤ .00093; relative risk = 2.68) and anxiety (32.90% vs 12.29%; p ≤ .00093; relative risk = 2.68) was higher in PwVWD. Most of the bleeding symptoms were associated with higher rates of depression and anxiety in PwVWD with the highest rates with abnormal uterine bleeding, hematemesis, hemoptysis, hematuria, and melena.

Conclusion: Our study shows that mental health disorders in PwVWD are a significant health burden, and that burden is increased with documented bleeding symptoms. It is important that primary care physicians and hematologists caring for this population recognize this increased risk and appropriately screen and refer to mental health professionals.

Keywords: anxiety; database; depression; population characteristics; von Willebrand disease.